CLINICAL ROLE -
Shockwave Therapy Improves Frozen Shoulder in Diabetes Patients
Diabetic patients who received non-invasive shockwave therapy for frozen shoulder had improved range of motion and diminished pain.
Read More
Rates of Hepatitis C Coinfection in Patients With HIV
For patients with HIV, liver disease is a major cause of morbidity and mortality.
Phase 3 Trial Shows High Cure Rates for Hepatitis C Drug
Glecaprevir is a NS3/4A protease inhibitor and pibrentasvir is a NS5A inhibitor for hepatitis C patients without cirrhosis.
Novel Hepatitis C Drug Shows High Cure Rates
Glecaprevir/pibrentasvir is indicated as an eight-week treatment for hepatitis C among patients without cirrhosis.
Hepatitis C Drug Gets European Approval
Zepatier is already approved in the United States and Canada for treatment of hepatitis C.
Hepatitis C Mortality Increases Over Last Decade
HCV-related deaths continued to rise while deaths from 60 other infectious diseases declined.
HCV-Related Liver Cancer Rates Rise as Other Cancers Fall
Deaths related to liver cancer from hepatitis C virus increase during a time when overall cancer deaths continue to decline.
Additional Funding Approved for Veterans with Hepatitis C
Expanded federal funding allows Department of Veterans Affairs to fund care for all veterans with hepatitis C.
Treatment Guidelines Updated for Hepatitis C Drug Zepatier
Zepatier can be used with or without ribavirin and does not require interferon.
Updated Hepatitis C Treatment Guidelines Issued for Zepatier
Zepatier is approved for the treatment of patients with chronic hepatitis C virus genotypes 1 and 4.
High Cholesterol Intake Increases Liver-Related Deaths in Women with HCV
Consuming less dietary cholesterol may reduce mortality or transplantation in women with hepatitis C.
Improved HCV Screening Needed at Community Health Centers
Rapid intervention helps patient with hepatitis C avoid cirrhosis, carcinoma, and end-stage liver disease.
Researchers Discover New Human Virus Linked to Hepatitis C
Human pegivirus-2 found only in patients with hepatitis C.
Prison Study to Focus on Substance Use and Hepatitis C Treatments
An estimated 500,000 incarcerated people in the US are currently infected with hepatitis C.
Senate Probe Slams Drug Maker for Jacking Up Price of Hepatitis C Pill
Gilead alleged to have priced and marketed Sovaldi to maximize revenue without regard to consequences for patients.
Study Probes Value of Hepatitis C Treatment at All Stages of Liver Fibrosis
Early treatment found to be cost-effective compared with waiting until liver fibrosis worsens.
Legislators focus on the pricing of sofosbuvir and Harvoni.
Urine Test Developed for Hepatitis C Infection
One-step test will screen, detect and confirm a hepatitis C virus infection.
Daklinza Approved in UK for Genotype 3 Hepatitis C Treatment
The once daily oral medication is for use with Sovaldi with or without ribavirin or in combination with peginterferon alfa and ribavirin.
Different Factors Impact Spontaneous Clearance of Hepatitis C
Immune mechanisms found to have significant impact on overcoming HCV.
Gilead Releases Topline Data on Investigational Hepatitis C Drug Velpatasvir
Velpatasvir is a pangenotypic NS5A inhibitor for patients with hepatitis C genotypes 1 through 6 of the virus.
Increase in Hepatitis C Rate Found Among Some HIV-Positive Men
Hepatitis C incidence rate among HIV-positive men who have sex with men grew three-fold from 1991 to 2010.
Hepatitis C Virus Enzyme Could Provide Novel Drug Target
Drug that targets interaction with RNA does not damage other proteins.
